- $332.87bn
- $411.51bn
- $49.95bn
- 99
- 20
- 95
- 82
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 39,506 | 39,068 | 40,479 | 42,440 | 49,954 |
Cost of Revenue | |||||
Gross Profit | 31,511 | 31,130 | 32,624 | 33,563 | 36,390 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 25,971 | 25,172 | 25,266 | 31,514 | 36,861 |
Operating Profit | 13,535 | 13,896 | 15,213 | 10,926 | 13,093 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 12,268 | 12,063 | 12,999 | 7,649 | 9,126 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10,694 | 10,135 | 13,746 | 6,717 | 8,503 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 11,083 | 10,135 | 13,746 | 6,717 | 8,503 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11,083 | 10,135 | 13,746 | 6,717 | 8,503 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.98 | 3.15 | 4.67 | 3.96 | 3.3 |
Dividends per Share |